NCT06728553 Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults Status COMPLETED Phase PHASE2
NCT06728345 The Real-world Study of Rimegepant Treatment in Female Migraine Patients of China Status NOT_YET_RECRUITING Phase N/A
NCT06716944 Self-acupuncture for Migraines Feasibility Study Status ENROLLING_BY_INVITATION Phase PHASE1/PHASE2
NCT06716489 Aerobic Exercise and Its Impact on Sensory, Musculoskeletal, and Psychosocial Aspects in Migraine Status RECRUITING Phase NA
NCT06701526 A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06695156 Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency, Intensity, and Functionality: A Single-Arm Study Status COMPLETED Phase NA
NCT06692881 Study to Assess Function and Satisfaction of Oral Ubrogepant in Adult Participants After Multiple Migraine Attacks In Canada Status COMPLETED Phase N/A
NCT06680206 Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey Status COMPLETED Phase N/A
NCT06675279 Psychometric Properties of the Turkish Version of the HANA in Migraine Status COMPLETED Phase N/A
NCT06674772 Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification Status RECRUITING Phase N/A
NCT06662461 Ultrasound Guided Block of Stellate Ganglion Versus Greater Occipital Nerve in Resistant Migraine and Correlation to Calcitonin Gene Related Peptide Status RECRUITING Phase NA
NCT06646081 The Impact of Greater Occipital Nerve and Stellate Ganglion Block Treatments on Sleep in Chronic Headache Management Status NOT_YET_RECRUITING Phase NA
NCT06628921 The Effectiveness of Eptinezumab During a Migraine Attack (the BE-FREE Study) Status RECRUITING Phase N/A
NCT06624137 Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics Status TERMINATED Phase N/A
NCT06616194 A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06603623 Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine Status COMPLETED Phase PHASE2
NCT06603558 Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine Status RECRUITING Phase N/A
NCT06602479 A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine Status RECRUITING Phase PHASE2